| 0.00 | 0.00% |
| SLXP Salix Pharmaceuticals Ltd. | Trade It Now | | NASDAQ |
| |
Market Cap 1.554B Book Value 4.826 EBITDA -30.2M Year Low 6.83 Year High 32.03 PEG Ratio 7.41 EPS -0.975 P/B Ratio 6.53 Short Ratio 3.30 Index Membership S&P 600 SmallCap S&P  Sector Healthcare Full Time Employees 280 Industry Drug Related Products Last Close 31.49 Target Price 40.56 Current EPS -0.975 This Year EPS 0.10 Next Year EPS 1.46 This Year PE 314.90 Next Year PE 21.57 Salix Pharmaceuticals Ltd.1700 Perimeter Park Drive Morrisville,
NC 27560-8404 United States - Map
Phone: 919-862-1000
Fax: 919-862-1095
Web Site: VisitType: Stock | | Salix Pharmaceuticals, Ltd., a specialty pharmaceutical company, engages in acquiring, developing, and commercializing prescription drugs used in the treatment of gastrointestinal disorders in the United States. |
Company Summary more  Salix Pharmaceuticals, Ltd., a specialty pharmaceutical company, engages in acquiring, developing, and commercializing prescription drugs used in the treatment of gastrointestinal disorders in the United States. Its products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers’ diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Azasan, a drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis. The company also offers ... Salix Pharmaceuticals, Ltd., a specialty pharmaceutical company, engages in acquiring, developing, and commercializing prescription drugs used in the treatment of gastrointestinal disorders in the United States. Its products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers’ diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Azasan, a drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis. The company also offers Anusol-HC and Proctocort, the hydrocortisone creams and suppositories for use in inflamed hemorrhoids and postirradiation proctitis, as well as an adjunct in the treatment of chronic ulcerative colitis and inflammatory conditions; Pepcid and Diuril oral suspensions, which are used for gastrointestinal indications that include the treatment of duodenal ulcer, benign gastric ulcer, and gastro esophageal reflux diseases; Apriso, for the maintenance of remission of ulcerative colitis in adults; and Colazal capsules for the treatment of ulcerative colitis. Salix Pharmaceuticals’ products under development include Balsalazide Disodium tablets for ulcerative colitis; Crofelemer for HIV-associated diarrhea; Vapreotide acetate for acute esophageal variceal bleeding; and Metoclopramide-Zydis for the treatment of gastroesphageal reflux and gastroparesis. It has collaboration agreements with aaiPharma LLC; Alfa Wassermann S.P.A.; Biorex Laboratories Limited; Cedars—Sinai Medical Center; ALW Partnership; Debiopharm Group; Dr. Falk Pharma GmbH; King Pharmaceuticals, Inc.; Merck & Co., Inc.; Napo Pharmaceuticals, Inc.; Norgine B.V.; and Wilmington Pharmaceuticals, LLC. The company was founded in 1989 and is headquartered in Morrisville, North Carolina. Salix Pharmaceuticals, Ltd., a specialty pharmaceutical company, engages in acquiring, developing, and commercializing prescription drugs used in the treatment of gastrointestinal disorders in the United States. Its products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers’ diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Azasan, a drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis. The company also offers ... Top Stories| | 2010-03-10 |  | |
| | |
Salix Pharmaceuticals Guides Below Estimates
Trading Markets - Mar 9, 2010
Salix Pharmaceuticals Ltd. (NASDAQ: SLXP) said it expects a first quarter loss of $0.50 per share with total product revenue of $40.0 million. The current consensus estimate is a loss of $0.07 per ...
2010-03-09 |  | |
| | | 2010-03-09 |  | |
| | | 2010-03-09 |  | |
|
| | A rally among airlines and a surprise jump in factory orders pushed US stocks higher in choppy trading on Tuesday. 2010-03-11 |  | |
|
Community Discussions | | | 0.00 | 0.00% |
| | Trade It Now | | NYSE |
| |
Market Cap 2.579B Book Value 5.969 EBITDA 359.8M Year Low 12.57 Year High 45.18 PEG Ratio 0.84 EPS 3.223 P/E 13.27 P/B Ratio 7.17 Short Ratio 3.40 Sector Healthcare Full Time Employees 4,100 Industry Drug Related Products Last Close 42.77 Target Price 50.83 Current EPS 3.223 This Year EPS 3.73 Next Year EPS 4.25 Current PE 13.27 This Year PE 11.47 Next Year PE 10.06 Dividend 0.80 Dividend Yield 1.87 Dividend Date Mar 16 Herbalife Ltd.Ugland House South Church Street Grand Cayman,
Cayman Islands - Map
Phone: 310-410-9600
Fax: 310-258-7019
Web Site: VisitType: Stock | | Herbalife Ltd., a network marketing company, sells weight management, nutritional supplement, energy, sports and fitness, and personal care products worldwide. |
Company Summary more  Herbalife Ltd., a network marketing company, sells weight management, nutritional supplement, energy, sports and fitness, and personal care products worldwide. It offers science based products in four principal categories: weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. The company’s weight management product portfolio includes meal replacement shakes, weight-loss enhancers, appetite suppressors, and a range of healthy snacks. Its targeted nutrition products comprise dietary supplements, which contain herbs, vitamins, minerals, and natural ingredients that support good health. The company’s energy, sports, and fitness products consist of energy and is... Herbalife Ltd., a network marketing company, sells weight management, nutritional supplement, energy, sports and fitness, and personal care products worldwide. It offers science based products in four principal categories: weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. The company’s weight management product portfolio includes meal replacement shakes, weight-loss enhancers, appetite suppressors, and a range of healthy snacks. Its targeted nutrition products comprise dietary supplements, which contain herbs, vitamins, minerals, and natural ingredients that support good health. The company’s energy, sports, and fitness products consist of energy and isotonic drinks to support a healthy active lifestyle. Its outer nutrition products include skin cleansers, toners, moisturizers and facial masks, shampoos and conditioners, anti-aging products, body-wash items, and a selection of fragrances for men and women. The company also sells literature and promotional materials, including sales aids, informational audiotapes, videotapes, CDs, and DVDs designed to support its distributors’ marketing efforts, as well as start-up kits for new distributors. It sells its products through a network of independent distributors, as well as through its retail stores and sales force in China. The company was founded in 1980 and is based in Grand Cayman, Cayman Islands. Herbalife Ltd., a network marketing company, sells weight management, nutritional supplement, energy, sports and fitness, and personal care products worldwide. It offers science based products in four principal categories: weight management; targeted nutrition; energy, sports, and fitness; and outer nutrition. The company’s weight management product portfolio includes meal replacement shakes, weight-loss enhancers, appetite suppressors, and a range of healthy snacks. Its targeted nutrition products comprise dietary supplements, which contain herbs, vitamins, minerals, and natural ingredients that support good health. The company’s energy, sports, and fitness products consist of energy and is... Top Stories| |
Herbalife - Growth And Income - Zacks Rank Buy
Benzinga - Mar 10, 2010
Herbalife (HLF) is expected to grow its earnings per share at 13.5% for the next five years. This Zacks Rank #2 stock also pays a decent dividend. Herbalife Ltd. is a global network marketing ...
2010-03-10 |  | |
| | | 2010-03-08 |  | |
| | |
Top 10 Pharmaceutical Stocks with Highest Return on Equity: BSTC, SNTS, HLF, ALXN, GSK, LLY, AZN, QCOR, CSKI, MRK (Mar 08, 2010)
China Analyst - Mar 8, 2010
Below are the top 10 Pharmaceutical stocks with highest Return on Equity ratio for the last 12 months. One Chinese company is on the list. BioSpecifics Technologies Corp. (NASDAQ:BSTC) has the 1st ...
2010-03-08 |  | |
| | |
Uptrend Spotted in Shares of Herbalife (HLF)
Comtex Smartrend - Mar 7, 2010
By Chip Brian, SmarTrend Analytics Team SmarTrend identified an Uptrend for Herbalife (NYSE:HLF) on February 17, 2010 at $40.12. In approximately 2 weeks, Herbalife has returned 6.8% as of today's ...
2010-03-07 |  | |
|
Community Discussions |